Effect of electronic prescription on attainment of cholesterol goals

Clinical Cardiology

Volumn 34, Issue 4, 2011, Pages 254-260

  Michelis, Katherine C ^a   Hassouna, Bassel ^a   Owlia, Mina ^a   Kelahan, Linda ^a   Young, Heather A ^a   Choi, Brian G ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; ARTICLE; DECISION SUPPORT SYSTEM; DRUG COST; ELECTRONIC MEDICAL RECORD; ELECTRONIC PRESCRIBING; FEMALE; FOLLOW UP; GOAL ATTAINMENT; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; OUTPATIENT; PHYSICIAN; PRESCRIPTION; RETROSPECTIVE STUDY;

ACADEMIC MEDICAL CENTERS; AGED; BIOLOGICAL MARKERS; CHOLESTEROL, LDL; DECISION SUPPORT TECHNIQUES; DISTRICT OF COLUMBIA; DRUG COSTS; DRUGS, GENERIC; DYSLIPIDEMIAS; ELECTRONIC PRESCRIBING; FEMALE; FORMULARIES AS TOPIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79953702238     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20861     Document Type: Article

References (25)

1. Cannon CP, Steinberg BA, Murphy SA, et al. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol. 2006;48:438-445. (Pubitemid 44109954)
2. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-1278.
3. Expert Panel onDetection Evaluation and Treatment of High Blood Cholesterol in Adults. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143-3421.
4. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. J Am Coll Cardiol. 2004;44:720-732.
5. Waters DD, Brotons C, Chiang C, et al. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. Circulation. 2009;120:28-34.
6. Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455-461. (Pubitemid 34787476)
7. Medicare Improvements for Patients and Providers Act of 2008, Public Law 110-275. HR 6331, 132 (July 15, 2008).
8. Health Information Technology Act of 2009. S. 179 (January 8, 2009).
9. Teich JM, Merchia PR, Schmiz JL, et al. Effects of computerized physician order entry on prescribing practices. Arch Intern Med. 2000;160:2741-2747.
10. Fischer MA, Vogeli C, Stedman M, et al. Effect of electronic prescribing with formulary decision support on medication use and cost. Arch Intern Med. 2008;168:2433-2439.
11. Doshi JA, Zhu J, Lee BY, Kimmel SE, et al. Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation. 2009;119:390-397.
12. Choudhry NK. Copayment levels and medication adherence: less is more. Circulation. 2009;119:365-367.
13. U.S. Food and Drug Administration. FDA approves first generic simvastatin: third new generic approved this week. FDA news release. July 2006 . http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108675.htm. Accessed January 4, 2010.
14. Kastelein JJP, Akdim F, Stroes ESG, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008;358:1431-1443. (Pubitemid 351482735)
15. Drugstore.com Web site. Prescription price checker. http://www.drugstore. com/prescriptions/qxc10663. Accessed October 7, 2009.
16. Turchin A, Shubina M, Chodos AH, et al. Effect of board certification on antihypertensive treatment intensification in patients with diabetes mellitus. Circulation. 2008;117:623-628.
17. Van Doormaal JE, van den Bemt PM, Zaal RJ, Egberts ACG, Lenderink BW, Kosterink JGW, Haaijer-Ruskamp FM, Mol PGM. The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted time-series study. J Am Med Inform Assoc. 2009;16:816-825.
18. Miller M, Byington R, Hunninghake D, et al. Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Arch Intern Med. 2000;160:343-347. (Pubitemid 30075216)
19. Ford ES, Mokdad AH, Giles WH, et al. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation. 2003;107:2185-2189.
20. Arnett DK, Jacobs DR Jr, Luepker RV, et al. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002. Circulation. 2005;112:3884-3891.
21. Mosca L, Merz NB, Blumenthal RS, et al. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting. Circulation. 2005;111:488-493. (Pubitemid 40204434)
22. Bodenheimer T, Wagner EH, Grumbach K. Improving Primary Care for Patients with Chronic Illness. JAMA. 2002;288:1775-1779.
23. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA. 2002;288:1909-1914. (Pubitemid 35168149)
24. van Wyk JT, van Wijk MAM, Sturkenboom MCJM, et al. Electronic alerts versus on-demand decision support to improve dyslipidemia treatment: A cluster randomized controlled trial. Circulation. 2008;117:371-378.
25. Bertoni AG, Bonds DE, Chen H, et al. Impact of a multifaceted intervention on cholesterolmanagement in primary care practices. Arch Intern Med. 2009;169:678-686.